Evidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23

American Journal of Human Genetics

Volumn 66, Issue 6, 2000, Pages 1845-1856

  Kort, E N ^a,e   Ballinger, D G ^b   Ding, W ^b   Hunt, S C ^c   Bowen, B R ^d   Abkevich, V ^b   Bulka, K ^b   Campbell, B ^b   Capener, C ^b   Gutin, A ^b   Harshman, K ^b   McDermott, M ^b   Thorne, T ^b   Wang, H ^b   Wardell, B ^b   Wong, J ^b   Hopkins, P N ^c   Skolnick, M ^b   Samuels, Mark E ^b  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b Utah   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^e Cimarron Software Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ACUTE HEART INFARCTION; ARTICLE; CHROMOSOMAL LOCALIZATION; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; GENE CLUSTER; GENE LOCUS; GENETIC LINKAGE; GENETIC MARKER; HUMAN; HYPOLIPOPROTEINEMIA; ISCHEMIC HEART DISEASE; PEDIGREE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033912373     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302945     Document Type: Article

References (66)

1. Adams TD, Hunt SC, Mason LA, Ramirez ME, Fisher AG, Williams RR (1993) Familial aggregation of morbid obesity. Obes Res 1:261-270
2. Acton S, Osgood D, Donoghue M, Corella D, Pocovi M, Cenarro A, Mozas P, et al (1999) Association of polymorphisms at the SR-BI gene locus with plasma lipid levels and body mass index in a white population. Arterioscler Thromb Vasc Biol 19:1734-1743
3. Almasy L, Hixson JE, Rainwater DL, Cole S, Williams JT, Mahaney MC, VandeBerg JL, et al (1999) Human pedigree-based quantitative-trait-locus mapping: localization of two genes influencing HDL-cholesterol metabolism. Am J Hum Genet 64:1686-1693
4. Bodzioch M, Orso E, Klucken J, Langmann T, Bottcher A, Diederich W, Drobnik W, et al (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat Genet 22:347-351
5. Boright AP, Connelly PW, Brunt JH, Scherer SW, Tsui LC, Hegele RA (1998) Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites. Atherosclerosis 139:131-136
6. Breslow JL (1995) Familial disorders of high-density lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, vol 2, pp 2031-2052
7. Broman KW, Murray JC, Sheffield VC, White RL, Weber JL (1998) Comprehensive human genetic maps: individual and sex-specific variation in recombination. Am J Hum Genet 63:861-869
8. Brooks-Wilson A, Marcil M, Clee SM, Zhang L-H, Roomp K, van Dam M, Yu L, et al (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22:336-345
9. Brownstein MJ, Carpten JD, Smith JR (1996) Modulation of non-templated nucleotide addition by Taq polymerase: primer modifications that facilitate genotyping. Biotechniques 20:1004-1010
10. Bu X, Warden CH, Xia Y-R, DeMeester C, Puppione DL, Teruya S, Lokens B, et al (1994) Linkage analysis of the genetic determinants of high density lipoprotein concentrations and composition: evidence for involvement of the apolipoprotein A-II and cholesteryl ester transfer protein loci. Hum Genet 93:639-648
11. Clerget-Darpoux F, Bonaïti-Pellié C (1986) Effects of misspecifying genetic parameters in lod score analysis. Biometrics 42:393-399
12. Cohen JC, Wang Z, Grundy SM, Stoesz MR, Guerra R (1994) Variation at the hepatic lipase and apolipoprotein AI/CIII/ AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J Clin Invest 94: 2377-2384
13. Conneally PM, Edwards JH, Kidd KK, Lalouel J-M, Morton NE, Ott J, White R (1985) Report of the committee on methods of linkage analysis and reporting. Cytogenet Cell Genet 40:356-359
14. Connelly PW, Hegele RA (1998) Hepatic lipase deficiency. Crit Rev Clin Lab Sci 35:547-572
15. Cottingham RW Jr, Idury RM, Schaffer AA (1993) Faster sequential genetic linkage computations. Am J Hum Genet 53: 252-263
16. Cupples, LA, Ordovas JM, Rao VS, Harmon MD, Wilson PWF, Schaefer EJ, Myers RH (1998) Evidence of a gene at 6q for high levels of high density lipoprotein cholesterol: the Framingham study. Am J Hum Genet 63 Suppl:A16 (abstract 78)
17. Dammerman M, Sandkuul LA, Halaas JL, Chung W, Breslow JL (1993) An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 90:4562-4566
18. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, et al (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380:152-154
19. Fisher RM, Humphries SE, Talmud PJ (1997) Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 135:145-159
20. Franceschini G, Sirtori CR, Capurso A, Weisgraber KH, Mahley RW (1980) A-I Milano apoprotein: decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66:892-900
21. Friedlander Y, Kark JD, Stein Y (1986) Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic. Hum Hered 36:143-153
22. Funke H, von Eckardstein A, Pritchard PH, Karas M, Albers JJ, Assmann G (1991) A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin:cholesterol acyltransferase deficiency, and corneal opacities. J Clin Invest 87:371-376
23. Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH, Silberman SR, et al (1992) Familial lipoprotein disorders in patients with premature coronary artery disease. Circulation 85:2025-2033
24. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG (1973) Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52:1544-1568
25. Hanson RL, Ehm MG, Pettitt DJ, Prochazka M, Thompson DB, Timberlake D, Foroud T, et al (1998) An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians. Am J Hum Genet 63: 1130-1138
26. Huang W, Sasaki J, Matsunaga A, Nanimatsu H, Moriyama K, Han H, Kugi M, et al (1998) A novel homozygous missense mutation in the Apo A-I gene with Apo A-I deficiency. Arterioscler Thromb Vasc Biol 18:389-396
27. Hunt SC, Hasstedt SJ, Kuida H, Stults BM, Hopkins PN, Williams RR (1989) Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol 129:625-638
28. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC (1998) Genome-wide searches for genes influencing serum lipid concentrations in Pima Indians. Am J Hum Genet 63 Suppl:A293 (abstract 1695)
29. Jaquish CE, Fabsitz RR, Larson MG, Cupples LA, Myers RH, Levy D (1998) A genome scan for quantitative trait loci influencing adiposity in the Framingham heart study. Am J Hum Genet 63 Suppl:A329 (abstract 1905)
30. Kamboh MI, Bunker CH, Aston CE, Nestlerode CS, McAllister AE, Ukoli FA (1999) Genetic association of five apolipoprotein polymorphisms with serum lipoprotein-lipid levels in African blacks. Genet Epidemiol 16:205-222
31. Kaprio J, Ferrell RE, Kottke BA, Kamboh MI, Sing CF (1991) Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler Thromb 11:1330-1348
32. Kuivenhoven JA, Pritchard H, Hill J, Frohlich J, Assmann G, Kastelein J (1997) The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38:191-205
33. Lander E, Green P (1987) Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci USA 84: 2363-2367
34. Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241-247
35. Lathrop GM, Lalouel J-M (1984) Easy calculations of LOD scores and genetic risks on small computers. Am J Hum Genet 36:460-465
36. Lathrop GM, Lalouel J-M, Julier C, Ott J (1984) Strategies for multilocus analysis in humans. Proc Natl Acad Sci USA 81:3443-3446
37. Lathrop GM, Lalouel J-M, White RL (1986) Construction of human genetic linkage maps: likelihood calculations for multilocus analysis. Genet Epidemiol 3:39-52
38. Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, Seilhamer JJ, et al (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 104:R25-R31
39. Litt M, Kramer P, Kort E, Fain P, Cox S, Root D, White R, et al (1995) The CEPH consortium linkage map of human chromosome 11. Genomics 27:101-112
40. Lipid Research Clinics (1980) Population studies data book. Vol I: the prevalence study. NIH publication no. 80-1527, US Department of Health and Human Services, Washington, DC
41. Maheny MC, Blangero J, Rainwater DL, Comuzzie AG, VandeBerg JL, Stern MP MacCluer JW, et al (1995) A major locus influencing plasma high-density lipoprotein cholesterol levels in the San Antonio family heart study. Arterioscler Thromb Vasc Biol 15:1730-1739
42. Nestlerode CS, Bunker CH, Sanghera DK, Aston CE, Ukoli FA, Kamboh MI (1999) Apolipoprotein J polymorphisms and serum HDL cholesterol levels in African blacks. Hum Biol 71:197-218
43. O'Connell JR, Weeks DE (1998) PedCheck: a program for identification of genotype incompatibilites in linkage analysis. Am J Hum Genet 63:259-266
44. Ott J (1977) Linkage analysis with misclassification at one locus. Clin Genet 12:119-124
45. -(1983) Linkage analysis and family classification under heterogeneity. Ann Hum Genet 47:311-320
46. Pajukanta P, Terwilliger JD, Perola M, Hiekkalinna T, Nuotio I, Ellonen P, Parkkonen M, et al (1999) Genomewide scan for familial combined hyperlipidemia genes in Finnish families, suggesting multiple susceptibility loci influencing triglyceride, cholesterol and apolipoprotein B levels. Am J Hum Genet 64:1453-1463
47. Peacock RE, Hamsten A, Johansson J, Nilsson-Ehle P, Humphries SE (1994) Associations of genotypes at the apolipoprotein AI-CIII-AIV, apolipoprotein B and lipoprotein lipase gene loci with coronary atherosclerosis and high density lipoprotein subclasses. Clin Genet 46:273-282
48. Perusse L, Despres JP, Tremblay A, Leblanc C, Talbot J, Allard C, Bouchard C (1989) Genetic and environmental determinants of serum lipids and lipoproteins in French Canadian families. Arteriosclerosis 9:308-318
49. Pocovi M, Cenarro A, Civeira F, Torralba MA, Perez-Calvo JI, Mozas P, Giraldo P, et al (1998) Beta-glucocerebrosidase gene locus as a link for Gaucher's disease and familial hypoalpha-lipoproteinaemia. Lancet 351:1919-1923
50. Prenger VL, Beaty TH, Kwiterovich PO (1992) Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients. Am J Hum Genet 51:1047-1057
51. Risch N, Giuffra L (1992) Model misspecification and multipoint linkage analysis. Hum Hered 42:77-92
52. Romling R, von Eckardstein A, Funke H, Motti C, Fragiacomo GC, Noseda G, Assmann G (1994) A nonsense mutation in the apolipoprotein A-I gene is associated with high-density lipoprotein deficiency and periorbital xanthelasmas. Arterioscler Thromb 14:1915-1922
53. Rust S, Rosier M, Funke H, Real J, Amoura Z, Piette J-C, Deleuze J-F, et al (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet 22:352-355
54. Schaffer AA, Gupta SK, Shriram K, Cottingham RW Jr (1994) Avoiding recomputation in linkage analysis. Hum Hered 44: 225-237
55. Smith CAB (1961) Homogeneity test for linkage data. Proc Sec Int Congr Hum Genet 1:212-213
56. Tall AR, Breslow JL (1996) Plasma high-density lipoproteins and atherogenesis. In: Fuster V, Ross R, Topol EJ (eds) Ath erosclerosis and coronary artery disease. Lippincott-Raven, Philadelphia, pp 105-128
57. Thomas A, Gutin A, Abkevich V, Bansal A. Multilocus linkage analysis by blocked Gibbs sampling. Stat Comput (in press)
58. Utermann G, Steinmetz A, Paetzold R, Wilk J, Feussner G, Kaffarnik H, Mueller-Eckhardt C, et al (1982) Apolipoprotein AI (Marburg): studies of two kindreds with a mutant of human apolipoprotein AI. Hum Genet 61:329-337
59. Von Eckardstein A, Funke H, Henke A, Altland K, Benninghoven A, Assman G, Welp S, et al (1989) Apolipoprotein A-I variants: naturally occurring substitutions of proline residues affect plasma concentration of apolipoprotein A-I. J Clin Invest 84:1722-1730
60. Warnick GR, Wood PD (1995) National cholesterol education program recommendations for measurement of high-density lipoprotein cholesterol: executive summary. Clin Chem 41: 1427-1433
61. Wijsman EM, Brunzell JD, Jarvik GP, Austin MA, Motulsky AG, Deeb SS (1998) Evidence against linkage of familial combined hyperlipidemia to the apolipoprotein AI-CIII-AIV gene complex. Arterioscler Thromb Vasc Biol 18:215-226
62. Williams RR, Hopkins PN, Hunt SC, Wu LL, Hasstedt SJ, Lalouel JM, Ash KO, et al (1990) Population-based frequency of dyslipidemia syndromes in coronary-prone families in Utah. Arch Intern Med 150:582-588
63. Wojciechowski AP, Farrall M, Cullen P, Wilson TME, Bayliss JD, Farren B, Griffin BA, et al (1991) Familial combined hyperlipidaemia linked to the apolipoprotein AI-CIII-AIV gene cluster on chromosome 11q23-q24. Nature 349: 161-164
64. Wu LL, Warnick GR, Wu JT, Williams RR, Lalouel JM (1989) A rapid micro-scale procedure for determination of total lipid profile. Clin Chem 35:1486-1491
65. Yamakawa-Kobayashi K, Yanagi H, Fukayama H, Hirano C, Shimakura Y, Yamamoto N, Arinami T, et al (1999) Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey. Hum Mol Genet 8:331-336
66. Yamashita S, Arai T, Hirano K, Sakai N, Ishigami M, Nakajima N, Matsuzawa Y (1996) Molecular disorders of cholesteryl ester transfer protein. J Atheroscler Thromb 3:1-11